Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
First Bancorp
FBNC
$2.74B
| $3.88M | 0.01% |
205,700
+5,094
| +3% | +$94.9K |
|
1802
ASE Group
ASX
$103B
| $3.87M | 0.01% |
+661,082
| New | +$3.6M |
|
|
STB
1803
DELISTED
Student Transportation Inc
STB
| $3.87M | 0.01% |
761,944
+98,844
| +15% | +$414K |
|
|
LSG
1804
DELISTED
LAKE SHORE GOLD CORP
LSG
| $3.87M | 0.01% |
2,647,598
-231,300
| -8% | -$274K |
|
1805
Nice
NICE
$5.99B
| $3.86M | 0.01% |
59,544
-113,200
| -66% | -$6.78M |
|
1806
eHealth
EHTH
$39.1M
| $3.86M | 0.01% |
410,800
+136,300
| +50% | +$1.35M |
|
1807
Expedia Group
EXPE
$39.9B
| $3.86M | 0.01% |
35,759
-92,095
| -72% | -$9.82M |
|
|
IMPR
1808
DELISTED
IMPRIVATA, INC COM
IMPR
| $3.85M | 0.01% |
305,100
-9,500
| -3% | -$108K |
|
1809
Diodes
DIOD
$4.77B
| $3.85M | 0.01% |
191,527
+4,800
| +3% | +$92.1K |
|
|
CRC
1810
DELISTED
California Resources Corporation
CRC
| $3.85M | 0.01% |
+373,651
| New | +$4.41M |
|
1811
Kforce
KFRC
$1.04B
| $3.85M | 0.01% |
196,349
+5,802
| +3% | +$112K |
|
1812
ASML
ASML
$708B
| $3.83M | 0.01% |
37,667
-298,782
| -89% | -$27M |
|
1813
Agree Realty
ADC
$9.3B
| $3.82M | 0.01% |
99,400
-72,968
| -42% | -$2.65M |
|
1814
Manchester United
MANU
$4.17B
| $3.82M | 0.01% |
264,474
+204,574
| +342% | +$3.03M |
|
|
JNS
1815
DELISTED
Janus Capital Group Inc
JNS
| $3.81M | 0.01% |
+260,600
| New | +$3.39M |
|
|
SYNH
1816
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.81M | 0.01% |
92,400
-50,300
| -35% | -$2.07M |
|
1817
Climb Global Solutions
CLMB
$532M
| $3.81M | 0.01% |
890,000
+8,000
| +0.9% | +$35K |
|
1818
Genesis Energy
GEL
$1.93B
| $3.8M | 0.01% |
+119,600
| New | +$3.33M |
|
1819
Core Molding Technologies
CMT
$224M
| $3.79M | 0.01% |
304,100
-10,999
| -3% | -$124K |
|
1820
La-Z-Boy
LZB
$1.67B
| $3.79M | 0.01% |
141,800
-76,700
| -35% | -$1.79M |
|
|
USAK
1821
DELISTED
USA Truck Inc
USAK
| $3.79M | 0.01% |
201,300
+26,400
| +15% | +$426K |
|
|
SCG
1822
DELISTED
Scana
SCG
| $3.77M | 0.01% |
+53,800
| New | +$3.48M |
|
1823
Icahn Enterprises
IEP
$5.27B
| $3.77M | 0.01% |
59,824
+24,327
| +69% | +$1.4M |
|
|
IPXL
1824
DELISTED
Impax Laboratories, Inc.
IPXL
| $3.77M | 0.01% |
117,700
+33,900
| +40% | +$1.19M |
|
|
GIG
1825
DELISTED
GigPeak, Inc.
GIG
| $3.77M | 0.01% |
1,395,600
+203,512
| +17% | +$545K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.